GigInternational1 (GIW) Peer Comparison
$10.17
$-0.01
(-0.10%)
As on 07-Oct-2026 16:00EDT
Market cap
$482 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Edit
| GigInternational1 (GIW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
482 | 5,286 | 3,321 | 668 | 441 |
Revenue ($ Mln) |
-- | 440 | 2,883 | -- | 330 |
Net Profit ($ Mln) |
3.04 | -1,435.01 | -118.30 | -134.20 | 100.20 |
Net Margin (%) |
-- | -325.91 | -4.10 | -- | 30.33 |
RoE (%) |
2.34 | -- | -- | -40.17 | 30.44 |
Price to Earnings |
-- | -- | -- | -- | 4.62 |
Price-To-Book |
-- | -- | 1.35 | -- | 1.27 |
Income Statement ($ Mln)
| GigInternational1 (GIW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 440.31 | 2,882.50 | 0.00 | 330.38 |
|
Cost of Revenue
|
0.00 | 315.99 | 1,742.40 | 0.00 | 98.94 |
|
Gross Profit
|
-- | 37.90 | 1,047.40 | -- | 289.40 |
|
Operating Expenses
|
1.03 | 272.77 | 986.50 | 39.92 | 98.29 |
|
Operating Profit (EBIT)
|
-1.03 | -148.31 | 153.60 | -39.94 | 133.14 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
5.77 | -1,432.28 | -95.60 | -134.22 | 133.14 |
|
Provision for Tax
|
2.73 | 2.73 | 17.60 | 0.00 | 32.95 |
|
Profit after Tax (Net Income)
|
3.04 | -1,435.01 | -118.30 | -134.20 | 100.20 |
|
Minority Interest
|
0.00 | 0.00 | -3.50 | 0.00 | 0.00 |
|
Consolidated Profit
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities ($ Mln)
| GigInternational1 (GIW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
260.56 | -2,419.36 | -1,200.20 | 268.28 | 340.79 |
|
Minority Interest
|
0.00 | 0.00 | -3.50 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
0.08 | 4,939.06 | 3,070.40 | 14.49 | 165.03 |
|
Current Liabilities
|
0.04 | 2,737.79 | 3,320.70 | 139.87 | 737.97 |
|
Total Liabilities
|
255.27 | 2,347.64 | 5,244.20 | 415.91 | 1,072.73 |
Assets ($ Mln)
| GigInternational1 (GIW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
259.82 | 2,813.85 | 3,874.70 | 421.02 | 345.92 |
|
Current Assets
|
0.85 | 2,443.64 | 1,458.30 | 1.61 | 897.87 |
|
Total Assets
|
255.27 | 2,347.64 | 5,244.20 | 415.91 | 1,072.73 |
|
Total Debt*
|
0.00 | 4,297.97 | 3,938.70 | 0.00 | 152.54 |
|
Net Current Assets
|
0.73 | -294.15 | -1,862.40 | -138.25 | 0.00 |
Cashflow ($ Mln)
| GigInternational1 (GIW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-- | 278.25 | 24.80 | -0.63 | 71.03 |
|
Cash Flow from Investing Activities
|
-- | -740.75 | -12.20 | -414.00 | 0.62 |
|
Cash from Financing Activities
|
-- | -63.10 | 114.30 | 415.37 | -1.08 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| GigInternational1 (GIW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-- | -120.97 | -7.47 | -- | 24.90 |
|
ROE (%)
|
2.34 | 32.38 | 17.08 | -40.17 | 30.44 |
|
ROA (%)
|
2.33 | -27.24 | -1.40 | -47.70 | 4.45 |
|
EBIT Margin (%)
|
-- | -318.56 | 4.14 | -- | 43.35 |
|
Net Margin (%)
|
-- | -325.91 | -4.10 | -- | 30.33 |
|
Cash Profit Margin (%)
|
-- | 0.00 | 0.00 | -- | 0.00 |
Growth Ratios
| GigInternational1 (GIW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 26.37 | -8.00 | -- | 3.36 |
|
EBIT Growth (%)
|
-- | -789.20 | 59.79 | -- | 18.91 |
|
Net Profit Growth (%)
|
-- | -32.71 | 39.02 | -- | 23.92 |
|
EPS Growth (%)
|
-- | -16.65 | 40.24 | -- | 23.42 |
|
Book Value Growth (%)
|
5,753,319.55 | -122.11 | 2.36 | 7,895,814.75 | 17.38 |
Valuation Ratios
| GigInternational1 (GIW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -19.80 | -13.35 | -- | 5.90 |
|
Price / Book Value
|
-- | -5.94 | -2.07 | -- | 1.99 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-- | -31.10 | 5.65 | -- | 2.71 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| GigInternational1 (GIW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | -1.78 | -1.80 | 0.00 | 0.44 |
|
Short term debt to equity ratio
|
0.00 | 0.00 | -1.49 | 0.00 | 0.00 |
|
Current Ratio
|
23.14 | 0.89 | 0.44 | 0.01 | 1.22 |
|
Quick Ratio
|
23.14 | 0.89 | 0.44 | 0.01 | 1.22 |
|
Interest Coverage
|
-- | -46.07 | 0.55 | -- | 14.23 |
Operating Efficiency Ratios
| GigInternational1 (GIW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 87.16 | 32.14 | -- | 74.70 |
|
Asset Turnover
|
0.00 | 0.08 | 0.34 | 0.00 | 0.15 |
|
Receivable days
|
-- | 193.60 | 125.70 | -- | 281.90 |
|
Inventory Days
|
-- | -- | -- | -- | -- |
|
Payable days
|
-- | 94.44 | 58.42 | -- | 1,383.94 |
|
Cash Conversion Cycle
|
-- | -- | -- | -- | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
